A quarter of the S&P 500 companies report earnings next week, and that could buffet the market as investors await the July Fed meeting.Market Insiderread more
Iran's Revolutionary Guard claims a British tanker it still holds, Stena Impero, failed to follow international maritime rules.World Newsread more
Amazon hires Trump-allied lobbyist Jeff Miller as battle for Pentagon contract heats up.Politicsread more
In a series of tweets, the president addressed an unusual controversy stemming from a speech delivered Thursday by New York Fed President John Williams.Marketsread more
"You need to understand that we're about to embark on the busiest week of the year for industrial earnings," CNBC's Jim Cramer says.Mad Money with Jim Cramerread more
Boston Federal Reserve President Eric Rosengren is lining up against an apparent push to cut interest rates, telling CNBC in an interview Friday that the central bank can...The Fedread more
The MTA reported that the 1, 2, 3, 4, 5 and 6 trains are all facing delays due to a network communications issue impacting service in both directions, NBC New York reports.Transportationread more
Companies aren't waiting for the U.S.-China trade war to be resolved, says the head of the world's biggest money manager.Investingread more
US officials including Treasury Secretary Steven Mnuchin and White House economic adviser Larry Kudlow will host a meeting at the White House on Monday of semiconductor and...Technologyread more
Trump's constant berating of the Fed and its actions does not influence the central bank's decisions, Boston Fed's Eric Rosengren says.The Fedread more
The lawsuits allege J&J's talc-based baby powder contained asbestos and caused ovarian and other cancers.Health and Scienceread more
When some well-regarded health-tech entrepreneurs decided to start a venture dubbed Ooda Health, they had their pick of venture capital firms.
So they made an unusual step of narrowing it down to investors at firms with strong female leadership. That's a small group, since only about 8 percent of partners at venture firms are women. And many of them do not have a background in health and technology.
After a months-long process, co-founders Seth Cohen, Giovanni Colella and Annie Lamont, an investor who also led Ooda's $2 million seed round, opted for Emily Melton, a health investor from the venture firm DFJ, to lead the first institutional round. Among other qualifications, Melton is involved in an initiative called All Raise, which aims to increase the number of women in the senior ranks of venture capital.
Melton told CNBC she heard about the venture through the grapevine and was impressed with the team. So she reached out to Colella, a doctor whom Melton has known since her early days in venture; Colella previously sold a patient-doctor communications start-up, RelayHealth, to medical distributor McKesson.
Cohen and Colella hail from Castlight Health, which went public in 2014. Ooda hasn't shared many specifics about its plans, but the founders said they're hoping to rework the broken health-care payment system. It is honing in on the billions of waste that racks up when money shifts from insurers to health providers, including doctors.
The founding team is looking to use its connections in the industry to reform this system of payment, starting off by paying doctors much more quickly than usual after they see a patient.
"There's so much opportunity through economies of scale and efficiencies to fix health care, which I see as a social and moral imperative," Melton said.
Cohen agreed that the mission is big, explaining that the founding team came together to "go into battle and do something compelling."
Along with DFJ, the company also received an investment from Lamont's fund, Oak HC/FT, as well as from some insurer customers, including Blue Shield of California. The company has now raised a total of $32.5 million.
Ooda's investors agree that the company's decision sends a powerful message, but that they ultimately came on board because they see a strong investment opportunity at a time when insurers are looking for new models, consumers are increasingly paying health expenses out of pocket and large employers are fed up with the status quo.
Both agree that diversity in venture could improve when entrepreneurs care about the issue — and when they have the power to insist on it in their funding partners.
Lamont, who also invested Castlight and in other health-tech successes like Athenahealth, said she hopes other entrepreneurs will follow suit.
"In some ways, [Cohen and Colella] have the luxury of doing this," said Lamont. "But I certainly think it sends a message, and I feel like the industry is sitting up and taking notice."